comparemela.com

Abbvie Skyrizi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dupixent repeats as top pharma ad brand, rankings largely unchanged in May

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology Holdings (NASDAQ:ALXO)

AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of Skyrizi (risankizumab) in the EU to treat adults with moderately to severely active ulcerative colitis (UC).

Innovent looks to Chinese regulators after ph 3 psoriasis win

Innovent looks to Chinese regulators after ph 3 psoriasis win
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Merck, other pharma giants brace for competition to blockbuster drugs

Merck, other pharma giants brace for competition to blockbuster drugs
qz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from qz.com Daily Mail and Mail on Sunday newspapers.

Dupixent recaptures top Rx, OTC pharma brand spot in April

Dupixent recaptures top Rx, OTC pharma brand spot in April
mmm-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mmm-online.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.